Patents Examined by Ba K. Trinh
  • Patent number: 5985912
    Abstract: Compounds of the formula The compounds are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: November 16, 1999
    Assignee: Pfizer Inc.
    Inventors: Bingwei Yang, Joyce Sutcliffe, Chris J. Dutton
  • Patent number: 5981777
    Abstract: The present invention provides new methods isolating taxanes and other metabolites from taxane-producing plant materials.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: November 9, 1999
    Assignee: The Regents of the University of California
    Inventors: Don J. Durzan, Frank F. Ventimiglia
  • Patent number: 5981768
    Abstract: A new class of stable dioxetanes bears a polycyclic stabilizing group and aryloxy moiety, the oxygen atom of which is provided with a protective group which can be removed by an enzymatic or chemical trigger admixed with the dioxetane. The polycyclic stabilizing group is preferably spiroadamantane. The group further bears an alkoxy, aryloxy, aralkyloxy or cycloalkyloxy moiety which is partially or completely substituted with halogens, particularly fluorine and chlorine. Proper selection of electron active groups on the stabilizing moiety, the aryl group and the OR group yields enhanced enzyme kinetics, superior light intensity and excellent detection sensitivity in various assays.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: November 9, 1999
  • Patent number: 5981765
    Abstract: The present invention provides a compound of formula ##STR1## wherein R.sup.1a is --H or --OR.sup.7a in which R.sup.7a is a hydroxy protecting group;R.sup.2a is --H, halo, or --OR.sup.8a in which R.sup.8a is a hydroxy protecting group;R.sup.6 is --H or a hydroxy protecting group which can be selectively removed;R.sup.11 is non-existent or .dbd.O; andZ is --O-- or --S--;or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: November 9, 1999
    Assignee: Eli Lilly and Company
    Inventors: Alan David Palkowitz, Kenneth Jeff Thrasher
  • Patent number: 5977382
    Abstract: The instant invention provides novel benzo[b]thiophene compounds, intermediates, compositions, pharmaceutical formulations, and methods of use.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: November 2, 1999
    Assignee: Eli Lilly and Company
    Inventor: Alan David Palkowitz
  • Patent number: 5977375
    Abstract: A compound of the formula I: ##STR1## wherein Ar represents an aryl radical;R.sub.1 represents a hydrogen atom, an aroyl radical, or a radical of the formula R.sub.4 --O--CO;R.sub.2 and R.sub.3 together form a 5- or 6-membered saturated heterocycle;G.sub.1 represents an acetyl radical or a protecting group of the hydroxyl functional group; andG.sub.2 represents a protecting group of the hydroxyl functional group.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: November 2, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Noel Denis, Andrew-Elliot Greene, Jean-Manuel Mas
  • Patent number: 5973171
    Abstract: An integrated process is provided for the production of propylene oxide from propane wherein propane is dehydrogenated to propylene and hydrogen and the resulting propylene, propane, and hydrogen mixture together with added oxygen is reacted over a palladium on titanium silicilite catalyst to form propylene oxide, the molar ratio of oxygen to hydrogen in the reaction feed being at least about 2/1.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: October 26, 1999
    Assignee: ARCO Chemical Technology, LP
    Inventors: Robert N. Cochran, John C. Jubin, Jr., Mark A. Liepa, Robert Nedwick, Rangasamy Pitchai, W. Wayne Wentzheimer
  • Patent number: 5973163
    Abstract: The present invention relates to novel oxazolidinecarboxylic acids. These oxazolidinecarboxylic acids are useful intermediates for the esterification of taxane synthons to provide taxanes esterified with an isoserine residue.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: October 26, 1999
    Assignee: INDENA S.p.A.
    Inventors: Ezio Bombardelli, Paolo De Bellis, Bruno Gabetta
  • Patent number: 5973170
    Abstract: A chemical compound having the formula: wherein R is an alkyl group and M.sup.+ counterion is an alkali metal, and a process of making the same.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: October 26, 1999
    Assignees: NaPro BioTherapuetics, Inc., Bryn Mawr College
    Inventors: Nicholas J. Sisti, Charles S. Swindell
  • Patent number: 5972996
    Abstract: 4-Cyano-4-deformylsordarin derivatives are antifungal agents useful in the treatment and/or prevention of human and animal fungal infections, as well as in the control of phytopathogenic fungi in crops.
    Type: Grant
    Filed: July 28, 1998
    Date of Patent: October 26, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Jennifer Nielsen-Kahn, Bruce Tse
  • Patent number: 5969165
    Abstract: A high yield and high purity method for obtaining taxane analogues from a source containing taxanes. The method employs a polymeric resin membrane for separating the analogues under low pressure without the use of complex and expensive separation/purification steps currently provided in the art.
    Type: Grant
    Filed: January 7, 1999
    Date of Patent: October 19, 1999
    Assignee: 508037 (NB) Inc.
    Inventor: Jian Liu
  • Patent number: 5965739
    Abstract: This invention provides oxazolidine protected taxol analogs of the Formula: ##STR1## which are useful intermediates to make various taxol analogues.
    Type: Grant
    Filed: December 7, 1995
    Date of Patent: October 12, 1999
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert C. Kelly, Harvey I. Skulnick
  • Patent number: 5965566
    Abstract: The present invention is directed compositions of the formula: ##STR1## wherein: D is a residue of biologically active moiety;X is an electron withdrawing group;Y and Y' are independently O or S;(n) is zero (0) or a positive integer, preferably from 1 to about 12;wherein: R.sub.1 and R.sub.2 are independently selected from the group consisting of H, C.sub.1-6 alkyls, aryls, substituted aryls, aralkyls, heteroalkyls, substituted heteroalkyls and substituted C.sub.1-6 alkyls;wherein: R.sub.3 is a substantially non-antigenic polymer, C.sub.1-12 straight or branched alkyl or substituted allyl, C.sub.5-8 cycloalkyl or substituted cycloalkyl, carboxyalkyl, carboalkoxy alkyl, dialkylaminoalkyl, phenylalkyl, phenylaryl or ##STR2## wherein: R.sub.4 and R.sub.5 are independently selected from the group consisting of H, C.sub.1-6 alkyls, aryls, substituted aryls, aralkyls, heteroalkyls, substituted heteroalkyls, and substituted C.sub.1-6 alkyls or jointly form a cyclic C.sub.5 -C.sub.7 ring.
    Type: Grant
    Filed: August 20, 1997
    Date of Patent: October 12, 1999
    Assignee: Enzon, Inc.
    Inventors: Richard B. Greenwald, Annapurna Pendri, Hong Zhao
  • Patent number: 5965754
    Abstract: A process and catalyst for the direct oxidation of an olefin having three or more carbon atoms, such as propylene, by oxygen to an olefin oxide, such as propylene oxide. The process involves contacting the olefin with oxygen under reaction conditions in the presence of hydrogen and a catalyst. The catalyst comprises gold on a support of titanium dispersed on silica. The titanium phase is disorganized and substantially free of crystalline titanium dioxide, as determined by analytical methods, such as, high resolution transmission electron microscopy and Raman spectroscopy. Selectivity to olefin oxide is high at good conversions of the olefin. The time between catalyst regenerations is long, and the catalyst is readily regenerated.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: October 12, 1999
    Assignee: The Dow Chemical Company
    Inventors: Howard W. Clark, Robert G. Bowman, Joseph J. Maj, Simon R. Bare, George E. Hartwell
  • Patent number: 5962705
    Abstract: The present invention relates to a novel process for preparing dialkoxy derivatives of the taxoid family by direct alkylation of the two positions 7 and 10 of deacetylbaccatin or derivatives thereof which are esterified in position 13.
    Type: Grant
    Filed: November 17, 1998
    Date of Patent: October 5, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Eric Didier, Gilles Oddon, Denis Pauze, Patrick Leon, Didier Riguet
  • Patent number: 5962700
    Abstract: A process for the preparation of butyrolactones of the formula I ##STR1## where the substituents R.sup.1 and R.sup.2 are hydrogen, alkyl or hydroxyalkyl groups, or aryl and trialkylsilyl groups, if appropriate carrying inert: substituents, is described in which an alkyne of the formula IIR.sup.1 --C.tbd.C--R.sup.2 IIwhere the substituents have the meanings indicated above, is reacted under reducing conditions at elevated pressure and elevated temperature with carbon monoxide CO and hydrogen in the presence of a transition metal catalyst or with carbon monoxide and water in the presence of a transition metal catalyst.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: October 5, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Marc Heider, Thomas Ruhl, Jochem Henkelmann, Susanne Stutz, Thomas Preiss, Heinz Rutter, Martin Schafer, Arthur Hohn
  • Patent number: 5959125
    Abstract: Novel taxoids of general formula (I), wherein R is a substituted alkyl radical or an alkenyl, alkynyl, cycloalkyl, optionally substituted cycloalkenyl or phenyl radical, or an aromatic 5- or 6-membered heterocyclic radical; and Z is a hydrogen atom or a radical of general formula (II), wherein R.sub.1 is an optionally substituted benzoyl, thenoyl or furoyl radical or a radical R.sub.2 --O--CO, where R.sub.2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, optionally substituted phenyl, or heterocycl radical, and R.sub.3 is an aromatic heterocyclic, alkyl, alkenyl, alkynyl cycloalkyl, phenyl or naphthyl radical. The novel products of general formula (I), wherein Z is a radical of general formula (II), have remarkable antitumoral activity.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: September 28, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Herve Bouchard, Jean-Dominique Bourzat, Alain Commer.cedilla.on
  • Patent number: 5955620
    Abstract: A process for dehydrogenating 1,4-butanediol to .gamma.-butyrolactone in the gas phase in the presence of a copper-containing catalyst, wherein the catalyst contains 4-40% by weight of copper and 0-5% by weight of Na.sub.2 O, based on the total weight of the catalyst, on a carrier consisting of 80-100% by weight of SiO.sub.2 and 0-20% by weight of CaO.
    Type: Grant
    Filed: September 4, 1997
    Date of Patent: September 21, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Hans Jochen Mercker, Frank-Friedrich Pape, Joachim Simon, Andreas Henne, Michael Hesse, Ulrich Kohler, Roman Dostalek, Cristina Freire Erdbrugger, Detlef Kratz
  • Patent number: 5955621
    Abstract: The present invention provides new sources of taxanes and other metabolites from members of the order Coniferales that are not in the genus Taxus.
    Type: Grant
    Filed: April 24, 1997
    Date of Patent: September 21, 1999
    Assignee: The Regents of the University of California
    Inventors: Don J. Durzan, Frank Ventimiglia
  • Patent number: 5952371
    Abstract: The compounds of Formula I ##STR1## are useful as iumnunosuppressive agents.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: September 14, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Robert K. Baker, Frank Kayser, Jianming Bao, Andrew Kotliar, William H. Parsons, Kathleen M. Rupprecht